The use of artificial neural networks for the selection of the most appropriate formulation and processing variables in order to predict the in vitro dissolution of sustained release minitablets

The objective of this work was to apply artificial neural networks (ANNs) to examine the relative importance of various factors, both formulation and process, governing the in-vitro dissolution from enteric-coated sustained release (SR) minitablets. Input feature selection (IFS) algorithms were used in order to give an estimate of the relative importance of the various formulation and processing variables in determining minitablet dissolution rate. Both forward and backward stepwise algorithms were used as well as genetic algorithms. Networks were subsequently trained using the back propagation algorithm in order to check whether or not the IFS process had correctly located any unimportant inputs. IFS gave consistent rankings for the importance of the various formulation and processing variables in determining the release of drug from minitablets. Consistent ranking was achieved for both indices of the release process; ie, the time taken for release to commence through the enteric coat (Tlag) and that for the drug to diffuse through the SR matrix of the minitablet into the dissolution medium (T90-10). In the case of the Tlag phase, the main coating parameters, along with the original batch blend size and the blend time with lubricant, were found to have most influence. By contrast, with the T90-10 phase, the amounts of matrix forming polymer and direct compression filler were most important. In the subsequent training of the ANNs, removal of inputs regarded as less important led to improved network performance. ANNs were capable of ranking the relative importance of the various formulations and processing variables that influenced the release rate of the drug from minitablets. This could be done for all main stages of the release process. Subsequent training of the ANN verified that removal of less relevant inputs from the training process led to an improved performance from the ANN.

[1]  Robert D. Johnson,et al.  Application of Neural Computing in Pharmaceutical Product Development , 1991, Pharmaceutical Research.

[2]  A. Sakr,et al.  Artificial neural network analysis of a direct compression tabletting study , 1995 .

[3]  Heekuck Oh,et al.  Neural Networks for Pattern Recognition , 1993, Adv. Comput..

[4]  M C Meyer,et al.  Relating formulation variables to in vitro dissolution using an artificial neural network. , 1997, Pharmaceutical development and technology.

[5]  K. Leiviskä,et al.  The advantages by the use of neural networks in modelling the fluidized bed granulation process , 1994 .

[6]  J. Richards,et al.  Batch Variation of Magnesium Stearate and its Effect on the Dissolution Rate of Salicylic Acid from Solid Dosage Forms , 1982 .

[7]  G E Peck,et al.  Pharmaceutical granulation and tablet formulation using neural networks. , 1996, Pharmaceutical development and technology.

[8]  R. Erb,et al.  Introduction to Backpropagation Neural Network Computation , 1993, Pharmaceutical Research.

[9]  O. Corrigan,et al.  Effects of surface active characteristics and solid state forms on the pH solubility profiles of drug–salt systems , 1998 .

[10]  M C Meyer,et al.  The application of an artificial neural network and pharmacokinetic simulations in the design of controlled-release dosage forms. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[11]  Ajaz S. Hussain,et al.  Feasibility of Developing a Neural Network for Prediction of Human Pharmacokinetic Parameters from Animal Data , 1993, Pharmaceutical Research.

[12]  Sanjeev S. Tambe,et al.  Estimating diffusion coefficients of a micellar system using an artificial neural network , 1995 .

[13]  J Bourquin,et al.  Basic concepts of artificial neural networks (ANN) modeling in the application to pharmaceutical development. , 1997, Pharmaceutical development and technology.

[14]  Robert D. Johnson,et al.  Application of Neural Computing in Pharmaceutical Product Development: Computer Aided Formulation Design , 1994 .

[15]  J. D. Watt The effect of the particle size of microcrystalline cellulose on tablet properties in mixtures with magnesium stearate , 1987 .

[16]  Kauko Leiviskä,et al.  Effect of neural network topology and training end point in modelling the fluidized bed granulation process , 1994 .